BIOSTEM U.S. CORP Stock-Based Compensation
BIOSTEM U.S. CORP reported Stock-Based Compensation of $2.88 million for the 9-month period ending 2012-11-30, per its 10-Q filed 2012-12-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2012-12-17
- BIOSTEM U.S. CORP share-based payment arrangement, noncash expense for the quarter ending 2012-11-30 was $400.00K, a 1451.71% increase year-over-year.
- BIOSTEM U.S. CORP share-based payment arrangement, noncash expense for the quarter ending 2012-08-31 was $1.81M.
- BIOSTEM U.S. CORP share-based payment arrangement, noncash expense for the quarter ending 2012-05-31 was $664.37K.
- BIOSTEM U.S. CORP share-based payment arrangement, noncash expense for the quarter ending 2011-11-30 was $25.78K.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month |
|---|---|---|---|
| 2012-11-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-12-17 | $2.21M derived: sum of 2 quarters · filed 2012-12-17 | $2.88M 10-Q · filed 2012-12-17 |
| 2012-08-31 | $1.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-10-19 | $2.48M 10-Q · filed 2012-10-19 | |
| 2012-05-31 | $664.37K 10-Q · filed 2012-07-12 | ||
| 2011-11-30 | $25.78K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-12-17 | $1.09M 10-Q · filed 2012-12-17 | |
| 2011-08-31 | $1.07M 10-Q · filed 2012-10-19 |